Atai Life Sciences Net Income 2020-2025 | ATAI

Atai Life Sciences net income from 2020 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Atai Life Sciences Annual Net Income
(Millions of US $)
2024 $-149
2023 $-40
2022 $-152
2021 $-168
2020 $-170
2019 $-14
Atai Life Sciences Quarterly Net Income
(Millions of US $)
2025-03-31 $-26
2024-12-31 $-39
2024-09-30 $-26
2024-06-30 $-57
2024-03-31 $-27
2023-12-31 $-18
2023-09-30 $44
2023-06-30 $-33
2023-03-31 $-33
2022-12-31 $-45
2022-09-30 $-34
2022-06-30 $-37
2022-03-31 $-37
2021-12-31 $-89
2021-09-30 $-31
2021-06-30 $-48
2021-03-31 $1
2020-12-31 $-87
2020-09-30 $-83
2020-06-30 $-16
2020-03-31 $16
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.383B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.032B 18.75
Encompass Health (EHC) United States $12.081B 25.61
DaVita (DVA) United States $10.634B 14.95
Chemed (CHE) United States $8.357B 26.26
Elanco Animal Health (ELAN) United States $6.268B 13.43
Option Care Health (OPCH) United States $5.356B 23.88
RadNet (RDNT) United States $4.356B 276.48
Amedisys (AMED) United States $3.072B 20.66
LifeStance Health (LFST) United States $2.205B 0.00
Addus HomeCare (ADUS) United States $2.027B 22.25
Astrana Health (ASTH) United States $1.412B 34.99
U.S Physical Therapy (USPH) United States $1.174B 30.31
Aveanna Healthcare Holdings (AVAH) United States $1.071B 61.00
Pennant (PNTG) United States $0.987B 36.24
MEDIROM Healthcare Technologies (MRM) Japan $0.051B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00